8th European Conference on Clinical Aspects and Treatment of HIV-infection, Athens, 28-31 October 2001

2 November 2001. Related: Conference reports, Conference index, EACS 8 Athens 2001.

Reports from the conference.

• HIV drug resistance can develop under HAART at low levels of viraemia

• Combinations of lopinavir/r and amprenavir in heavily treatment experienced patients

• Further reports of benefits of polylactic acid for facial lipoatrophy

• GigaHAART study shows benefit of treatment interruption prior to treatment with >7 drugs in highly treatment experienced patients

• Tenofovir DF 907 study

• The Max Cmin 1 trial: indinavir/ritonavir vs. saquinavir/ritonavir

• No significant drug interactions found between tenofovir DF and indinavir, lopinavir/r, lamivudine, or efavirenz

• Ritonavir corrects drug interaction between efavirenz and saquinavir

• Lopinavir/r effective in naive patients after three years of treatment